Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin
Phase of Trial: Phase III
Latest Information Update: 18 Jul 2013
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary) ; Insulins; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Jul 2013 New trial record
- 25 Jun 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.